Summit Therapeutics Inc. (SMMT)
Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.
Address
2882 SAND HILL ROAD
MENLO PARK, CA 94025
Founded
2003
Number of Employees
105
Website
http://www.smmttx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)